---
title: 'Statin, aspirin and metformin use and risk of hepatocellular carcinoma related
  outcomes following liver transplantation: A retrospective study'
date: '2024-09-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39295976/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240919194323&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Statin, metformin or aspirin use was not associated with
  improved HCC-related outcomes post-LT, in a largely historical cohort of Australian
  patients with a low proportion of NAFLD. Further prospective, multicentre studies
  are required to clarify any potential benefit of these drugs to improve HCC-related
  ...'
disable_comments: true
---
CONCLUSION: Statin, metformin or aspirin use was not associated with improved HCC-related outcomes post-LT, in a largely historical cohort of Australian patients with a low proportion of NAFLD. Further prospective, multicentre studies are required to clarify any potential benefit of these drugs to improve HCC-related ...